Lantheus Cerveau - A novel PET imaging agent for tau in Alzheimer’s …
At Lantheus Cerveau, our passion is to Find, Fight and Follow ® disease to deliver better patient outcomes. We’re committed to partnering with Alzheimer’s researchers in academia and the …
Science - Lantheus Cerveau
MK-6240 images from our Users Group and others are warehoused in the Lantheus Cerveau Image Core. Associated imaging, blood chemistry and cognitive assessments are often also archived. Great …
Contact - Lantheus Cerveau
© 2025 Lantheus Cerveau. All rights reserved. 201 Burlington Road, South Building, Bedford, MA 01730 [email protected] • 800-362-2668 PM-US-NP-0067 February 2024
Press Release - Lantheus Cerveau
May 4, 2020 · Cerveau Technologies Inc. and Prothena Sign Agreement to Provide Novel Tau Imaging Biomarker for Research and Development of Investigational Therapeutics for Neurodegenerative …
Publications - Lantheus Cerveau
This product candidate is an investigational drug that has not yet been approved as safe and effective.
Lantheus Cerveau
Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable …
Production Site Login - Lantheus Cerveau
© 2025 Lantheus Cerveau. All rights reserved. 201 Burlington Road, South Building, Bedford, MA 01730 [email protected] • 800-362-2668 PM-US-NP-0067 February 2024
Lantheus Cerveau - A novel PET imaging agent for tau in Alzheimer’s …
Lantheus Cerveau - A novel PET imaging agent for tau in Alzheimer’s disease
Form - Lantheus Cerveau
© 2025 Lantheus Cerveau. All rights reserved. 201 Burlington Road, South Building, Bedford, MA 01730 [email protected] • 800-362-2668 PM-US-NP-0067 February 2024